Try our Advanced Search for more refined results

Sanofi Fights Bid To Combine EpiPen Suits Against Mylan

By Melissa Daniels (May 15, 2017, 7:09 PM EDT) -- Sanofi-Aventis U.S. LLC urged the Judicial Panel on Multidistrict Litigation on Friday to deny a request to join its suit against Mylan Inc. over an alleged monopoly of EpiPen sales with others, saying its Sherman Act suit brings up different legal issues than putative class actions from direct and indirect purchasers of the pens....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!